{"title":"中国成人SLCO1B1多态性分布频率与血脂水平的关系","authors":"Q Mo, S Huang, J Ma, J Zhang, R Su, Q Deng","doi":"10.1080/09674845.2020.1785692","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The variation of serum lipid levels can be part-related to certain genes. One such gene, <i>SLCO1B1</i>, encodes a transporter that may have a role in lipid metabolism. We hypothesised that differences in certain <i>SLCO1B1</i> genotypes are related to levels of serum lipids.</p><p><strong>Materials and methods: </strong>We recruited 636 subjects who were genotyped for <i>SLCO1B1</i> variants *1a, *1b, *5 and *15. Routine liver function tests, renal function tests and routine lipid indices were measured by standard techniques.</p><p><strong>Results: </strong>The most frequent genotypes were *1b/*1b (29.3%), *1b/*15 (27.5%), *1a/*1b (21.1%), *1a/*15 and *1b/*5 (10.2%) and *1a/*1a (8.5%). There were significant differences in levels of triglycerides and HDL in the four <i>SLCO1B1</i> genotypes *1a/*1a, *1b/*1b, *1a/*1b and *1b/*15 (all p < 0.05).</p><p><strong>Conclusion: </strong>The genotypes *1a/*1a and *1a/*1b indicate a high risk of cardiovascular disease, while the *1b/*1b group may have a relatively low risk. <i>SLCO1B1</i> may be involved in the metabolism of triglycerides and HDL. We have provided a tool for identifying potentially high-risk groups that could be helpful for early diagnosis and prevention, individualized drug therapy and even gene therapy.</p>","PeriodicalId":9236,"journal":{"name":"British Journal of Biomedical Science","volume":"78 1","pages":"23-27"},"PeriodicalIF":2.7000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/09674845.2020.1785692","citationCount":"2","resultStr":"{\"title\":\"Association between <i>SLCO1B1</i> polymorphism distribution frequency and blood lipid level in Chinese adults.\",\"authors\":\"Q Mo, S Huang, J Ma, J Zhang, R Su, Q Deng\",\"doi\":\"10.1080/09674845.2020.1785692\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The variation of serum lipid levels can be part-related to certain genes. One such gene, <i>SLCO1B1</i>, encodes a transporter that may have a role in lipid metabolism. We hypothesised that differences in certain <i>SLCO1B1</i> genotypes are related to levels of serum lipids.</p><p><strong>Materials and methods: </strong>We recruited 636 subjects who were genotyped for <i>SLCO1B1</i> variants *1a, *1b, *5 and *15. Routine liver function tests, renal function tests and routine lipid indices were measured by standard techniques.</p><p><strong>Results: </strong>The most frequent genotypes were *1b/*1b (29.3%), *1b/*15 (27.5%), *1a/*1b (21.1%), *1a/*15 and *1b/*5 (10.2%) and *1a/*1a (8.5%). There were significant differences in levels of triglycerides and HDL in the four <i>SLCO1B1</i> genotypes *1a/*1a, *1b/*1b, *1a/*1b and *1b/*15 (all p < 0.05).</p><p><strong>Conclusion: </strong>The genotypes *1a/*1a and *1a/*1b indicate a high risk of cardiovascular disease, while the *1b/*1b group may have a relatively low risk. <i>SLCO1B1</i> may be involved in the metabolism of triglycerides and HDL. We have provided a tool for identifying potentially high-risk groups that could be helpful for early diagnosis and prevention, individualized drug therapy and even gene therapy.</p>\",\"PeriodicalId\":9236,\"journal\":{\"name\":\"British Journal of Biomedical Science\",\"volume\":\"78 1\",\"pages\":\"23-27\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1080/09674845.2020.1785692\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"British Journal of Biomedical Science\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/09674845.2020.1785692\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2020/7/22 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICAL LABORATORY TECHNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Biomedical Science","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/09674845.2020.1785692","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/7/22 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 2
摘要
背景:血脂水平的变化可能与某些基因有关。其中一个基因,SLCO1B1,编码一种转运蛋白,可能在脂质代谢中起作用。我们假设某些SLCO1B1基因型的差异与血脂水平有关。材料和方法:我们招募了636名受试者,对SLCO1B1 *1a、*1b、*5和*15变异进行基因分型。采用标准技术测定肝功能、肾功能及血脂指标。结果:最常见的基因型b * 1 / * 1 b (29.3%), b * 1 / * 15(27.5%)、* 1 / * 1 b (21.1%), b * 1 / * 15 * 1 / * 5(10.2%)和* 1 / * 1(8.5%)。SLCO1B1基因型*1a/*1a、*1b/*1b、*1a/*1b和*1b/*15的甘油三酯和HDL水平差异均有统计学意义(均p)。结论:*1a/*1a和*1a/*1b基因型提示心血管疾病的高危人群,而*1b/*1b基因型可能风险较低。SLCO1B1可能参与甘油三酯和HDL的代谢。我们已经提供了一种工具来识别潜在的高危人群,这可能有助于早期诊断和预防,个性化药物治疗,甚至基因治疗。
Association between SLCO1B1 polymorphism distribution frequency and blood lipid level in Chinese adults.
Background: The variation of serum lipid levels can be part-related to certain genes. One such gene, SLCO1B1, encodes a transporter that may have a role in lipid metabolism. We hypothesised that differences in certain SLCO1B1 genotypes are related to levels of serum lipids.
Materials and methods: We recruited 636 subjects who were genotyped for SLCO1B1 variants *1a, *1b, *5 and *15. Routine liver function tests, renal function tests and routine lipid indices were measured by standard techniques.
Results: The most frequent genotypes were *1b/*1b (29.3%), *1b/*15 (27.5%), *1a/*1b (21.1%), *1a/*15 and *1b/*5 (10.2%) and *1a/*1a (8.5%). There were significant differences in levels of triglycerides and HDL in the four SLCO1B1 genotypes *1a/*1a, *1b/*1b, *1a/*1b and *1b/*15 (all p < 0.05).
Conclusion: The genotypes *1a/*1a and *1a/*1b indicate a high risk of cardiovascular disease, while the *1b/*1b group may have a relatively low risk. SLCO1B1 may be involved in the metabolism of triglycerides and HDL. We have provided a tool for identifying potentially high-risk groups that could be helpful for early diagnosis and prevention, individualized drug therapy and even gene therapy.
期刊介绍:
The British Journal of Biomedical Science is committed to publishing high quality original research that represents a clear advance in the practice of biomedical science, and reviews that summarise recent advances in the field of biomedical science. The overall aim of the Journal is to provide a platform for the dissemination of new and innovative information on the diagnosis and management of disease that is valuable to the practicing laboratory scientist.